Risperidone-ISM® effectiveness and tolerability in acute schizophrenia patients hospitalised due to a relapse: results from an international, prospective, non-interventional evaluation (RESHAPE study).

Key Points

• Evaluate the effectiveness and tolerability of risperidone-ISM in patients with acute schizophrenia relapse.
• International, prospective, non-interventional design
• Assessment of acute schizophrenia patients
• Evaluation of effectiveness and tolerability outcomes
• Risperidone-ISM shows rapid and sustained effectiveness
• Functional improvement and favorable tolerability noted
• No added benefit from combining with another antipsychotic

Abstract